BEIJING, April 28 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will participate at the following investor conferences in May and June 2010:
Investor Conference Date Location
Deutsche Bank Access May 10-13, 2010 Marina Bay Sands Resort &
Asia Conference Casino, Singapore
2010 Citi Global Health May 26-27, 2010 Hilton, New York
Care Conference
J.P. Morgan China
Conference 2010 June 9-11, 2010 Grand Hyatt, Beijing
The Company's Chief Financial Officer, Mr. Sam Tsang, will discuss the Company's strategies, operations, growth opportunities as well as its published financial results to date with institutional investors during these investor conferences.
About China Medical Technologies, Inc.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology as well as Enhanced Chemiluminescence Immunoassay (ECLIA) technology, an immunodiagnostic technology to develop, manufacture and distribute diagnostic products for the detection of various cancers, diseases and disorders. The Company generates all revenues in China by selling diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales force and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com .
For more information, please contact:
Winnie Yam
Tel: +852-2511-9808
Email: IR@chinameditech.com
